Related Experiment Videos

[Treatment of aggressive non-Hodgkin's lymphoma]

U Kaiser¹, L Trümper, M Pfreundschuch

¹Zentrum für Innere Medizin, Klinikum der Philipps-Universität Marburg.

|February 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Role and responsibility of oncologists in assisted suicide. Practice and views among members of the German Society of Haematology and Medical Oncology.

ESMO open·2021

SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Effect of gloved hand disinfection on hand hygiene before infection-prone procedures on a stem cell ward.

The Journal of hospital infection·2019

Obesity negatively impacts outcome in elderly female patients with aggressive B-cell lymphomas treated with R-CHOP: results from prospective trials of the German high grade non-Hodgkin's lymphoma trial group.

British journal of haematology·2017

Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.

Leukemia·2017

See all related articles